Alaa H. Habib

Jeddah, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.

Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.

Journal: PloS one

Published: March 09, 2026

Aegeline mitigates isoproterenol-induced myocardial infarction: insights from biochemical, histopathological, and in silico studies.

Aegeline mitigates isoproterenol-induced myocardial infarction: insights from biochemical, histopathological, and in silico studies.

Journal: Frontiers in cardiovascular medicine

Published: February 05, 2026

MicroRNA-CRISPR biosensors for cancer diagnostics.

MicroRNA-CRISPR biosensors for cancer diagnostics.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 27, 2025

Fluorescent β-galactosidase biosensors for colon cancer.

Fluorescent β-galactosidase biosensors for colon cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 17, 2025

Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways.

Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways.

Journal: PloS one

Published: October 02, 2025

TP53 apoptosis biomarkers in breast cancer.

TP53 apoptosis biomarkers in breast cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 03, 2025

Targeting TNFR1-driven necroptosis in breast cancer.

Targeting TNFR1-driven necroptosis in breast cancer.

Journal: EXCLI journal

Published: August 28, 2025

Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.

Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.

Journal: PloS one

Published: August 28, 2025

Pathophysiology of Status Epilepticus Revisited.

Pathophysiology of Status Epilepticus Revisited.

Journal: International journal of molecular sciences

Published: June 24, 2025

Aloe Polysaccharides against 3-Nitropropionic acid-induced Huntington's disease-like symptoms: Role of BDNF/NF-κB/Nrf2 signaling pathways.

Aloe Polysaccharides against 3-Nitropropionic acid-induced Huntington's disease-like symptoms: Role of BDNF/NF-κB/Nrf2 signaling pathways.

Journal: Current neuropharmacology

Published: June 14, 2025

Translational potential of GADD45α: biomarker and therapeutic target in age-associated neurodegeneration and longevity.

Translational potential of GADD45α: biomarker and therapeutic target in age-associated neurodegeneration and longevity.

Journal: Biogerontology

Published: May 02, 2025

Cubebin Niosomal Suspension Attenuates DMBA-Induced Breast Cancer Through the Involvement of Estrogen and Progesterone Receptors and Oxidative/Inflammatory/CA 15-3 Tumor Marker.

Cubebin Niosomal Suspension Attenuates DMBA-Induced Breast Cancer Through the Involvement of Estrogen and Progesterone Receptors and Oxidative/Inflammatory/CA 15-3 Tumor Marker.

Journal: Journal of biochemical and molecular toxicology

Published: March 19, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026